UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Cholinesterase inhibitors for Alzheimer's disease

Cochrane database of systematic reviews, 2006-01, Vol.2016 (1), p.CD005593

Birks, J

2006

Volltextzugriff (PDF)

Donepezil for dementia in people with Down syndrome

Cochrane database of systematic reviews, 2009-01, Vol.2021 (1), p.CD007178

2009

Volltextzugriff (PDF)

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

The New England journal of medicine, 2016-06, Vol.374 (23), p.2222-2234

2016

Volltextzugriff (PDF)

Targeting renal cell carcinoma with a HIF-2 antagonist

Nature (London), 2016-11, Vol.539 (7627), p.112-117

2016

Volltextzugriff (PDF)

Donepezil for mild cognitive impairment

Cochrane database of systematic reviews, 2006-07 (3), p.CD006104

2006

Volltextzugriff (PDF)

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

The New England journal of medicine, 2021-09, Vol.385 (14), p.1280-1291

2021

Volltextzugriff (PDF)

Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

The Lancet (British edition), 2021-09, Vol.398 (10306), p.1184-1194

2021

Volltextzugriff (PDF)

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

The New England journal of medicine, 2016-05, Vol.374 (18), p.1754-1762

2016

Volltextzugriff (PDF)

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

Nature (London), 2016-11, Vol.539 (7627), p.107-111

2016

Volltextzugriff (PDF)

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Journal of Alzheimer's disease, 2014-01, Vol.41 (2), p.615-631

2014

Volltextzugriff (PDF)

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

American journal of respiratory and critical care medicine, 2018-08, Vol.198 (3), p.329-339

2018

Volltextzugriff (PDF)

Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

Progress in neurobiology, 2017-04, Vol.151, p.4-34

2017

Volltextzugriff (PDF)

Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate

Journal of medicinal chemistry, 2021-02, Vol.64 (4), p.1844-1855

2021

Volltextzugriff (PDF)

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

The New England journal of medicine, 2012-03, Vol.366 (10), p.893-903

2012

Volltextzugriff (PDF)

Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

European journal of medicinal chemistry, 2017-01, Vol.125, p.736-750

2017

Volltextzugriff (PDF)

Novel Targeted Therapies for Inflammatory Bowel Disease

Trends in pharmacological sciences (Regular ed.), 2017-02, Vol.38 (2), p.127-142

2017

Volltextzugriff (PDF)

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

The lancet respiratory medicine, 2013-03, Vol.1 (1), p.51-60

2013

Volltextzugriff (PDF)

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

Lancet neurology, 2014-11, Vol.13 (11), p.1092-1099

2014

Volltextzugriff (PDF)

Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

European journal of medicinal chemistry, 2016-11, Vol.123, p.282-297

2016

Volltextzugriff (PDF)

Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial

Journal of clinical oncology, 2015-05, Vol.33 (15), p.1653-1659

2015

Volltextzugriff (PDF)

Next generation of small molecules in inflammatory bowel disease

Gut, 2017-02, Vol.66 (2), p.199-209

2017

Volltextzugriff (PDF)

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

Clinical gastroenterology and hepatology, 2023-08, Vol.21 (9), p.2407-2409.e2

2023

Volltextzugriff (PDF)

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

American journal of respiratory and critical care medicine, 2017-05, Vol.195 (9), p.1189-1197

2017

Volltextzugriff (PDF)

Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis

Neurotherapeutics, 2017-10, Vol.14 (4), p.859-873

2017

Volltextzugriff (PDF)

1 – 25 von 2.225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.990)
Mit Volltextzugriff
(1.521)

Publikationsform

Sprache

13 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Indans - Therapeutic Use
(2.085)
Humans
(1.995)
Science & Technology
(1.747)
Life Sciences & Biomedicine
(1.718)
Piperidines - Therapeutic Use
(1.416)
Male
(1.174)
Cholinesterase Inhibitors - Therapeutic Use
(1.026)
Female
(1.004)
Aged
(967)
Alzheimer Disease - Drug Therapy
(937)
Neurosciences & Neurology
(683)
Donepezil
(676)
Middle Aged
(563)
Treatment Outcome
(556)
Biological And Medical Sciences
(537)
Alzheimer's Disease
(534)
Nootropic Agents - Therapeutic Use
(533)
Medical Sciences
(531)
Clinical Neurology
(494)
Pharmacology & Pharmacy
(451)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Cholinesterase inhibitors for Alzheimer's disease

Donepezil for dementia in people with Down syndrome

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

Targeting renal cell carcinoma with a HIF-2 antagonist

Donepezil for mild cognitive impairment

Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

Sphingosine 1-phosphate receptor modulators in multiple sclerosis and other conditions

Ozanimod Induction and Maintenance Treatment for Ulcerative Colitis

On-target efficacy of a HIF-2α antagonist in preclinical kidney cancer models

Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis

Long-Term Triple Therapy De-escalation to Indacaterol/Glycopyrronium in Patients with Chronic Obstructive Pulmonary Disease (SUNSET): A Randomized, Double-Blind, Triple-Dummy Clinical Trial

Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease

Kinetics-Driven Drug Design Strategy for Next-Generation Acetylcholinesterase Inhibitors to Clinical Candidate

Donepezil and Memantine for Moderate-to-Severe Alzheimer's Disease

Design, synthesis, in-silico and biological evaluation of novel donepezil derivatives as multi-target-directed ligands for the treatment of Alzheimer's disease

Novel Targeted Therapies for Inflammatory Bowel Disease

Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol–fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study

Safety and efficacy of idalopirdine, a 5-HT6 receptor antagonist, in patients with moderate Alzheimer's disease (LADDER): a randomised, double-blind, placebo-controlled phase 2 trial

Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of Alzheimer's disease

Donepezil for Irradiated Brain Tumor Survivors: A Phase III Randomized Placebo-Controlled Clinical Trial

Next generation of small molecules in inflammatory bowel disease

Ozanimod in the Treatment of Ulcerative Colitis: Initial Real-World Data From a Large Tertiary Center

Blood Eosinophils and Response to Maintenance Chronic Obstructive Pulmonary Disease Treatment. Data from the FLAME Trial

Nursing home placement in the Donepezil and Memantine in Moderate to Severe Alzheimer's Disease (DOMINO-AD) trial: secondary and post-hoc analyses

Sphingosine 1-Phosphate Receptor Modulators for the Treatment of Multiple Sclerosis

Suchergebnisse filtern